First human test of new 'Living Drug' for Tough-to-Treat cancers
Disease control
Recruiting now
This early-stage study is testing the safety and finding the right dose of a new personalized cell therapy called LEU011 for adults with advanced solid tumors that have come back or stopped responding to standard treatments. Doctors take a patient's own blood cells, modify them i…
Phase: PHASE1, PHASE2 • Sponsor: Leucid Bio • Aim: Disease control
Last updated Apr 02, 2026 03:26 UTC